Literature DB >> 3779638

Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas.

J V Tricoli, L B Rall, C P Karakousis, L Herrera, N J Petrelli, G I Bell, T B Shows.   

Abstract

The insulin-like growth factors I and II (IGF-I and -II) are proteins which stimulate cell proliferation and are important in normal human growth and development. They are coded for by separate genes and bind to specific cell surface receptors, eliciting a mitogenic response. IGFs are secreted by several cell lines derived from adult tumors. We have examined a number of human adult tumors for IGF messenger RNA (mRNA) expression and found IGF-II mRNA levels were consistently elevated in two types, colon carcinoma and liposarcoma. Adult colonic mucosa contains low levels of IGF-I and -II mRNA while several colon tumors, particularly of rectal and rectosigmoid origin, contained significantly elevated levels of IGF-II message. Over 90% of liposarcomas examined contained greatly elevated levels of IGF-II mRNA while control tissue (adipose) contained very low or undetectable IGF mRNA levels. Many of these tumors also contained elevated IGF-I mRNA levels. Northern analysis of these RNAs revealed differences in the abundance and sizes of IGF transcripts compared to other normal and malignant tissues known to express IGF.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3779638

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  61 in total

Review 1.  Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis.

Authors:  Okkyung Rho; Dae Joon Kim; Karou Kiguchi; John Digiovanni
Journal:  Mol Carcinog       Date:  2010-07-20       Impact factor: 4.784

Review 2.  The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence.

Authors:  M Davies; S Gupta; G Goldspink; M Winslet
Journal:  Int J Colorectal Dis       Date:  2005-06-16       Impact factor: 2.571

3.  IGF-I and IGF-I receptor in mouse colon cancer cells.

Authors:  P Singh; Y S Guo; S Narayan; Y Chandrasekhar
Journal:  In Vitro Cell Dev Biol       Date:  1991-10

4.  Expression of insulin-like growth factor II (IGF)-II) and H19 in murine teratocarcinomas derived from embryonic stem (ES) cells.

Authors:  N L Blythe; P V Senior; F Beck
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

5.  Insulin receptor isoform switching in intestinal stem cells, progenitors, differentiated lineages and tumors: evidence that IR-B limits proliferation.

Authors:  Sarah F Andres; James G Simmons; Amanda T Mah; M Agostina Santoro; Laurianne Van Landeghem; P Kay Lund
Journal:  J Cell Sci       Date:  2013-10-14       Impact factor: 5.285

6.  Insulin-like growth factor-1 messenger RNA isoforms in rat prostate and prostate tumors.

Authors:  F Wang; W L McKeehan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-05       Impact factor: 2.416

7.  Development of targeted therapy for a broad spectrum of solid tumors mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P4 and IGF2-P3 regulatory sequences.

Authors:  Doron Amit; Sagi Tamir; Abraham Hochberg
Journal:  Int J Clin Exp Med       Date:  2013-01-26

8.  Growth factor regulation of proliferation in primary cultures of small intestinal epithelium.

Authors:  C Booth; G S Evans; C S Potten
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

9.  Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: relevance to clonal growth of tumors.

Authors:  I Zvibel; E Halay; L M Reid
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

10.  Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome.

Authors:  H Schneid; D Seurin; M P Vazquez; M Gourmelen; S Cabrol; Y Le Bouc
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.